CFO DepartureCFO Sandra Beaver will be resigning from the company and Evolus has initiated the process to identify a successor.
Macroeconomic ConcernsSome investors may be concerned with the macro trends, given the significant volatility in the capital markets, consumer sentiment, and tariffs noise.
Market Growth ChallengesDespite a top-line miss, Evolus maintained full-year guidance due to acceleration in share gains in the toxin business, offsetting slower market growth.